World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
12112
World Ranking
12020
National Ranking
114

Philip Lazarovici publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Philip Lazarovici sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 259 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Philip Lazarovici D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Philip Lazarovici sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 60 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Philip Lazarovici is affiliated with the Hebrew University of Jerusalem in Israel. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on various subfields including Molecular Biology, Neurology, Physiology, Immunology and Allergy, and Oncology.

Lazarovici's scientific work addresses multiple topics, notably:

  • Cell Adhesion Molecules Research
  • Proteoglycans and glycosaminoglycans research
  • Glycosylation and Glycoproteins Research
  • Alzheimer's disease research and treatments
  • Sirtuins and Resveratrol in Medicine
  • Peptidase Inhibition and Analysis
  • COVID-19 Clinical Research Studies

Their publications have appeared frequently in several main venues, including:

  • International Journal of Biological Sciences
  • Cytokine & Growth Factor Reviews
  • Pharmaceuticals
  • Biomedicines
  • Preprints.org

Selected recent papers by Lazarovici include:

  • "Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy" (2021, International Journal of Biological Sciences)
  • "Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity" (2022, Cells)
  • "Pristimerin-induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway" (2020, Journal of Cellular and Molecular Medicine)
  • "Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer's Disease" (2022, Oxidative Medicine and Cellular Longevity)
  • "Pharmacological therapies and drug development targeting SARS-CoV-2 infection" (2022, Cytokine & Growth Factor Reviews)

Frequent collaborators include Limor Rubin, Michal Klazas, Chaim Gilon, Wenhua Zheng, and Majdi Saleem Naamneh. Their coauthorship involves multiple projects and publications, reflecting ongoing collaborative efforts in various domains of biomedical research.

Best Publications

  • Signaling pathways for PC12 cell differentiation: making the right connections.

    D. Vaudry;P. J. S. Stork;P. Lazarovici;L. E. Eiden

  • Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity.

    Gila Moalem;Amos Gdalyahu;Yael Shani;Uwe Otten

  • cAMP Response Element-Binding Protein (CREB): A Possible Signaling Molecule Link in the Pathophysiology of Schizophrenia

    Haitao Wang;Jiangping Xu;Philip Lazarovici;Remi Quirion

  • K-252a: a specific inhibitor of the action of nerve growth factor on PC 12 cells.

    Shinichi Koizumi;Margarita L. Contreras;Yuzuru Matsuda;Tokiko Hama

  • Regulation of the differentiation of PC12 pheochromocytoma cells.

    Ko Fujita;Philip Lazarovici;Gordon Guroff

  • Nerve growth factor–endothelial cell interaction leads to angiogenesis in vitro and in vivo

    Giuseppina Cantarella;Laurence Lempereur;Marco Presta;Domenico Ribatti

  • Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development.

    Philip Lazarovici;Cezary Marcinkiewicz;Peter I. Lelkes

  • Cell cycle-specific action of nerve growth factor in PC12 cells: differentiation without proliferation.

    B B Rudkin;P Lazarovici;B Z Levi;Y Abe

  • Purification and pore-forming activity of two hydrophobic polypeptides from the secretion of the Red Sea Moses sole (Pardachirus marmoratus).

    Philip Lazarovici;Naftali Primor;Leslie M. Loew

  • Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway.

    Haitao Wang;Qishan Zhang;Qiang Wen;Yongxin Zheng

  • Co-Electrospun Blends of PLGA, Gelatin, and Elastin as Potential Nonthrombogenic Scaffolds for Vascular Tissue Engineering

    Jingjia Han;Philip Lazarovici;Colin Pomerantz;Xuesi Chen

  • Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia.

    Rinat Tabakman;Philip Lazarovici;Ron Kohen

  • Interactions between the cells of the immune and nervous system: neurotrophins as neuroprotection mediators in CNS injury.

    Rinat Tabakman;Shimon Lecht;Stela Sephanova;Hadar Arien-Zakay

  • Expression and Activation of the Nerve Growth Factor Receptor TrkA in Serous Ovarian Carcinoma

    Ben Davidson;Reuven Reich;Philip Lazarovici;Jahn M. Nesland

  • Sequencing and synthesis of pardaxin, a polypeptide from the Red Sea Moses sole with ionophore activity.

    Yechiel Shai;Jay Fox;Carlo Caratsch;Yu-Liang Shih

  • The 38-amino-acid form of pituitary adenylate cyclase-activating polypeptide induces neurite outgrowth in PC12 cells that is dependent on protein kinase C and extracellular signal-regulated kinase but not on protein kinase A, nerve growth factor receptor tyrosine kinase, p21(ras) G protein, and pp60(c-src) cytoplasmic tyrosine kinase.

    Philip Lazarovici;Hao Jiang;Donald Fink

  • Rasagiline, a monoamine oxidase-B inhibitor, protects NGF-differentiated PC12 cells against oxygen-glucose deprivation.

    Saleh Abu-Raya;Eran Blaugrund;Victoria Trembovler;Eugenia Shilderman-Bloch

  • Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs.

    Marta Weinstock;Natanja Kirschbaum-Slager;Philip Lazarovici;Corina Bejar

  • The microbial alkaloid toxin staurosporine blocks the phorbol ester-induced increase in beta-amyloid precursor protein in PC12 cells.

    Lilach Mira Friedman;Yuzuru Matsuda;Philip Lazarovici

  • Neuroprotection by NGF in the PC12 in vitro OGD model: involvement of mitogen-activated protein kinases and gene expression.

    Rinat Tabakman;Hao Jiang;Iris Shahar;Hadar Arien-Zakay

Frequent Co-Authors

Arnon Nagler
Arnon Nagler Sheba Medical Center
Gordon Guroff
Gordon Guroff National Institutes of Health
Esther Shohami
Esther Shohami Hebrew University of Jerusalem
Ben Davidson
Ben Davidson Oslo University Hospital
Johannes A. Eble
Johannes A. Eble University of Münster
Eliahu Zlotkin
Eliahu Zlotkin Hebrew University of Jerusalem
Juan J. Calvete
Juan J. Calvete Spanish National Research Council
Jahn M. Nesland
Jahn M. Nesland Oslo University Hospital
Claes G. Tropé
Claes G. Tropé University of Oslo
George P. Tuszynski
George P. Tuszynski Temple University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Philip Lazarovici

Trending Scientists

Recently Published Articles